Dimensional Fund Advisors LP Increases Stock Position in Teleflex Incorporated (NYSE:TFX)

Dimensional Fund Advisors LP lifted its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 26.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 512,144 shares of the medical technology company's stock after buying an additional 108,189 shares during the period. Dimensional Fund Advisors LP owned about 1.10% of Teleflex worth $91,150,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the company. Headlands Technologies LLC purchased a new position in shares of Teleflex in the fourth quarter worth $29,000. Avior Wealth Management LLC increased its holdings in Teleflex by 81.2% in the 4th quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock worth $50,000 after buying an additional 125 shares in the last quarter. IFP Advisors Inc raised its position in Teleflex by 238.5% in the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock worth $55,000 after buying an additional 217 shares during the last quarter. Exchange Traded Concepts LLC lifted its stake in Teleflex by 38.2% during the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after acquiring an additional 94 shares during the period. Finally, R Squared Ltd bought a new stake in shares of Teleflex in the fourth quarter worth approximately $64,000. Hedge funds and other institutional investors own 95.62% of the company's stock.

Teleflex Stock Performance

Teleflex stock traded up $0.43 during midday trading on Friday, hitting $126.30. The stock had a trading volume of 753,291 shares, compared to its average volume of 638,415. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 52-week low of $124.66 and a 52-week high of $249.91. The company has a market capitalization of $5.86 billion, a PE ratio of 25.11, a P/E/G ratio of 1.73 and a beta of 1.19. The firm's fifty day moving average is $136.84 and its two-hundred day moving average is $171.53.

Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, beating the consensus estimate of $2.88 by $0.03. The firm had revenue of $700.67 million for the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company's revenue was down 5.0% on a year-over-year basis. During the same period last year, the firm earned $3.21 EPS. On average, research analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were issued a $0.34 dividend. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a yield of 1.08%. Teleflex's dividend payout ratio is presently 95.77%.

Wall Street Analysts Forecast Growth

TFX has been the topic of a number of research analyst reports. StockNews.com downgraded shares of Teleflex from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. Truist Financial dropped their price target on Teleflex from $149.00 to $140.00 and set a "hold" rating on the stock in a research note on Friday, April 11th. Morgan Stanley reduced their price objective on Teleflex from $275.00 to $191.00 and set an "overweight" rating for the company in a research report on Wednesday, March 5th. Citizens Jmp cut Teleflex from an "outperform" rating to a "market perform" rating in a research report on Thursday, February 27th. Finally, Bank of America lowered shares of Teleflex from a "neutral" rating to an "underperform" rating and reduced their price target for the company from $235.00 to $140.00 in a research report on Tuesday, March 4th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $167.25.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.